Evidence map›Paper›PMID 16085913›Full record

Trial reportClinical and diagnostic laboratory immunology2005

Lipoprotein-dependent and -independent immune responses to spirochetal infection.

Juan C Salazar, Constance D Pope, Meagan W Moore, Jonathan Pope, Thomas G Kiely, Justin D Radolf

Open access · diamondAbstract readClinical Trial
In one paragraph

Trial report in Clinical and diagnostic laboratory immunology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 49 citations in OpenAlex.

  1. Protective efficacy of mutant strains ofInfection and immunity · 2026
    Article
  2. Article
  3. B-Cell Epitope Mapping of theDiagnostics (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Immune Response toCurrent issues in molecular biology · 2021
    Article
  8. Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  9. Review
  10. Spirochetal Lipoproteins and Immune Evasion.Frontiers in immunology · 2017
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Syphilis: using modern approaches to understand an old disease.The Journal of clinical investigation · 2011
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Juan C SalazarDivision of Pediatric Infectious Diseases, Connecticut Children's Medical Center, 282 Washington Street, Hartford, Connecticut 06106, USA. jsalaza@ccmckids.org
Constance D Pope
Meagan W Moore
Jonathan Pope
Thomas G Kiely
Justin D Radolf
Microbial ID (United States) · USUConn Health · USGénétique et biologie du développementInstitut thématique Génétique, génomique et bioinformatique · FR

Funding

ZONISAMIDE VERSUS PLACEBOM01RR006192 · NCRR · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI DRAZINIC, CAROLYN M · 1994 to 2008
$22.1M
CUTANEOUS IMMUNE RESPONSE IN SECONDARY SYPHILISR01AI038894 · NIAID · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI RADOLF, JUSTIN D · 1996 to 2005
$2.1M
Immunity in Early Syphillis: Pathway to HIV CoinfectionK23AI062439 · NIAID · CONNECTICUT CHILDREN'S MEDICAL CENTER · PI SALAZAR, JUAN C · 2005 to 2007
$454k
NCRR NIH HHS M01 RR006192NCRR NIH HHS M01RR06192NIAID NIH HHS AI-38894NIAID NIH HHS K23 AI062439NIAID NIH HHS R01 AI038894
6 · The paper itself

Abstract

In this study, we used the epidermal suction blister technique, in conjunction with multiparameter flow cytometry, to analyze the cellular and cytokine responses elicited by intradermal injection of human volunteers with synthetic analogs for spirochetal lipoproteins and compared the responses to findings previously reported from patients with erythema migrans (EM). Compared with peripheral blood (PB), lipopeptides derived from the N termini of the Borrelia burgdorferi outer surface protein C and the 17-kDa lipoprotein of Treponema pallidum (OspC-L and 17-L, respectively) elicited infiltrates enriched in monocytes/macrophages and dendritic cells (DCs) but also containing substantial percentages of neutrophils and T cells. Monocytoid (CD11c(+)) and plasmacytoid (CD11c(-)) DCs were selectively recruited to the skin in ratios similar to those in PB, but only the former expressed the activation/maturation surface markers CD80, CD83, and DC-SIGN. Monocytes/macrophages and monocytoid DCs, but not plasmacytoid DCs, displayed significant increases in surface expression of Toll-like receptor 1 (TLR1), TLR2, and TLR4. Staining for CD45RO and CD27 revealed that lipopeptides preferentially recruited antigen-experienced T-cell subsets; despite their lack of antigenicity, these agonists induced marked T-cell activation, as evidenced by surface expression of CD69, CD25, and CD71. Lipopeptides also induced significant increases in interleukin 12 (IL-12), IL-10, gamma interferon, and most notably IL-6 without corresponding increases in serum levels of these cytokines. Although lipopeptides and EM lesional infiltrates shared many similarities, differences were noted in a number of immunologic parameters. These studies have provided in situ evidence for a prominent "lipoprotein effect" during human infection while at the same time helping to pinpoint aspects of the cutaneous response that are uniquely driven by spirochetal pathogens.

Indexed as

AdolescentAdultAgedBacterial Outer Membrane ProteinsBorrelia burgdorferi GroupCytokinesDendritic CellsFemaleHumansLipoproteinsMaleMiddle AgedMonocytesSkin TestsSpirochaetales InfectionsSyphilisBacterial Outer Membrane ProteinsCytokinesLipoproteins

Identifiers

PMID16085913
PMCPMC1182186
OpenAlexW2148665953

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.